Podcasts about Leukemia

Mom Curious is a weekly podcast produced by Hoff Studios in New York City, hosted by storyteller, actress, and thought leader Daniella Rabbani. Each episode dives into candid conversations about motherhood, womanhood, and the messy, magical spaces in between. With humor, honesty, and (you guessed it!) curiosity, Daniella sits down with women of all stripes to talk about what it really means to raise children—and ourselves—in today's world.About the Host:Daniella Rabbani (@DaniellaRabbani on Instagram) is a Brooklyn-based storyteller. On screen, she's appeared in HBO's Scenes from a Marriage, Amazon's The Better Sister, FX's The Americans, and films like Ocean's 8. On stage, she's headlined concerts worldwide, from Jazz at Lincoln Center in NYC to the State Jewish Theaters of Warsaw, Poland and Bucharest, Romania. She is also the voice behind national campaigns for Colgate, Starbucks, and Noom among others. Her award winning film OMA, inspired by her Holocaust survivor grandmother, can be seen on Amazon Prime.Through her podcast Mom Curious, Daniella blends her creative spirit and lived experience as a mother of two to spark conversations that are raw, hilarious, and deeply relatable. Her mission: to create a community where mothers (and those curious about motherhood) feel seen, supported, and inspired.This Week's Guest!Caitlin Murray is a humorist, content creator, writer, podcaster, mother of three and wife of one. She is the creator of Big Time Adulting. In 2016, Caitlin's oldest child was diagnosed with Leukemia at age three. Caitlin began sharing with family and friends about their journey and, specifically, her experience as a mother. Caitlin started her Instagram account in 2018 and has amassed over a million followers who appreciate her for her honest and humorous takes on motherhood. Her book comes out in 2026! Follow Caitlin at @bigtimeadulting on Instagram. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode we'll learn about targeting the tissue factor pathway inhibitor with a monoclonal antibody to rebalance HEMOSTASIS in hemophilia A and B. In the phase 3 BASIS trial, the monoclonal antibody marstacimab reduced bleeding events, and was generally well tolerated, with no unanticipated side effects. After that: matched-donor allogeneic CD19 CAR-T for adult B-ALL. Given after allogeneic transplantation, CAR-donor lymphocyte infusion after lymphodepleting chemotherapy was associated with favorable efficacy and a tolerable safety profile. Finally: a new prognostic index for mycosis fungoides and Sézary syndrome. Comprised of four prognostic factors, the “CLIPI” could enable more personalized treatment of cutaneous lymphomas, identifying patients who may benefit from intensified treatment.Featured ArticlesMarstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trialMatched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletionA new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

In this How I Treat podcast episode, Laura Michaelis, MD interviews Sung-Yun Pai, MD about their recently published article in Blood journal "How I treat Wiskott-Alrich syndrome". They highlight recent updates in treatment, including new risk-benefit calculations due to safer treatments and longer follow-ups. Challenges include late diagnosis, lack of well-matched donors, and limited gene therapy availability. They emphasize the importance of early referral to specialized centers and the need for discussions about curative intent therapies, including transplant and gene therapy. The conversation also covers the complexities of gene therapy, such as the need for better conditioning agents and the challenges of achieving full correction in all cell types.

Help us end childhood Cancer here: https://fundraising.stjude.org/site/TR/Heroes/SJMMW?px=5816464&pg=personal&fr_id=158671©_link_share Ministry Spotlight: Partners 4 Africa- http://partners4africa.com/ Healing Hands International is a proud sponsor of this podcast. Get more info about them here: https://www.hhi.org/ Will shares info about our ministry spotlight on "Partners 4 Africa". Ben and Travis then discuss Travis' leukemia battle and practical ways to stay encouraged while facing trials and scary moments. The episode wraps up with the Healing Hands International Question of the Day. Links mentioned in this episode: Get our free ebook "28 Days of Focused Living" here: https://www.benandtravis.com https://www.facebook.com/groups/benandtravis Reframing Hope Book: https://www.benandtravis.com/books For extra content and material you can use for your family or ministry go to https://www.patreon.com/benandtravis Represent the show: https://www.benandtravis.com/store The Friday ReFresh: https://podcasts.apple.com/us/podcast/the-friday-refresh/id1611969995 Good Old Fashioned Dislike Podcast: https://podcasts.apple.com/us/podcast/good-old-fashioned-dislike/id1643163790 Co-Producers: Justin B., Doris C., Rhonda F., Scott K., Mary H., Scott B. This podcast is hosted by ZenCast.fm

On this now two year anniversary, I felt that this deserved a replay! This is an episode that is an enormous part of why I've changed the brand of the podcast to encompass the broader human experience. My daughter, Jocelyn, is my very special guest today. She talks about her leukemia diagnosis over two years ago, and the battle that would take up all of 2023, and change the way she has to look at her health for the rest of her life. Hearing this story from her provides so much joy for who she is as a woman, how she's grown, and my hope is that you'll hear the same message.  She shares some of the early indicators that were thought to be a bad case of the flu, the mysterious bruises she got, and when she checked in to Phoenix Children's Hospital. She talks about shaving her head, the incredible people that stepped up for her when she was down, and the quirky things that people say and do - when they don't know what to say or do! The lesson and ongoing message in this podcast for all of us is, I believe, that through struggle and adversity comes strength. I'm so proud of my daughter - and the lessons I believe are important for anyone struggling.  I hope that you find this episode to be uplifting and motivating for your own human experience. Thank you so much for listening! Stacie More episodes at StacieBaird.com.

Guest: Dawn Guerrero Senior Manager, Patient & Community Outreach Blood Cancer United, formerly known as the Leukemia and Lymphoma Society, changed its name to better represent all types of blood cancers—of which there are over 100. The organization funds research, advocates for patients, and offers financial, emotional, and educational support to individuals and families affected by blood cancer. Their Dare to Dream Project focuses on improving treatment for children, recognizing that pediatric blood cancers differ from those in adults and require tailored care. bloodcancerunited.org

Evening Prayer (people with leukemia) #prayer #pray #eveningprayer #jesus #god #holyspirit #aimingforjesus #healing #bible #love #peace #leukemia Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peace aimingforjesus.com YouTube Channel https://www.youtube.com/@aimingforjesus5346 Instagram https://www.instagram.com/aiming_for_jesus/ Threads https://www.threads.com/@aiming_for_jesus X https://x.com/AimingForJesus Tik Tok https://www.tiktok.com/@aiming.for.jesus

In this week's episode, we'll learn more about relationships between Epstein-Barr virus genomic variants and human diseases, including hematological malignancies; the presence and timing of somatic GATA1 mutations and their relationship to a Down syndrome-specific form of leukemia; and new definitions for high-risk multiple myeloma that emphasize the presence of two or more high-risk cytogenetic abnormalities.Featured Articles:Association of Epstein-Barr virus genomic alterations with human pathologiesClinical significance of preleukemic somatic GATA1 mutations in children with Down syndromeBiallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma

Light the Night 2025 with Blood Cancer United (formerly Leukemia & Lymphoma Society)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After experiencing stomach pains and fevers in the spring of 2023, Jordan Vanstee's then 2 year old son Kian was diagnosed with B Cell Acute Lymphoblastic Leukemia. Kian went through very difficult treatment at McMaster's Children's Hospital in Canada , but with the help of his Disney Hero Mickey Mouse and the Make a Wish Foundation, Kian is now in remission and is living his best life possible. 

In this episode of The Bloodline with Blood Cancer United, Elissa and guest co-host, Kristen Parker, speak with Dr. Anand […] The post Acute Promyelocytic Leukemia (APL): Advances, Hope, and Healing first appeared on The Bloodline with Blood Cancer United Podcast.

This episode of WNY Brews is brought to you by The Tap and Craft Festival at Buffalo Riverworks on October 4th, presented by The Lock Tender. Ticket information is available now at BuffaloBeerLeague.com/tapandcraft.This week, we've got a lot to raise a glass to. Hofbrauhaus Buffalo is celebrating five years with a big Bavarian bash, and Southern Tier Buffalo is hosting Pumkingfest with all the seasonal favorites and variants you could want. Wayland Brewing is throwing their third annual Oktoberfest weekend with music, food, steins and even axe throwing, while Buffalo Riverworks is gearing up for the Tap & Craft Festival with a stacked brewery list. Resurgence brings back the Dude's Homebrew Competition in support of the Leukemia & Lymphoma Society, Big Ditch is taking over taps at Nickel City Cigars, and Fattey Beer Co. just opened a new Amherst location. Plus, Bev Depot is hosting a fall tasting with samples from Mortalis, Big Ditch, Thin Man, and more.You can find all of these stories and more at BuffaloBeerLeague.com.WNY Brews is hosted by Scott Panfil and Brian Campbell. Reach us anytime at Brian@BuffaloBeerLeague.com and Scott@WNYBrews.com. Hosted on Acast. See acast.com/privacy for more information.

In this inspiring episode of The Van Deeb Podcast, Van sits down with long-time friend and powerhouse leader Sandy Spady — founder of Power Up Leadership and Women With Voices. Sandy shares her journey of building confidence in others, creating a thriving community of nearly 4,000 women, and making a difference through volunteer work and leadership coaching. From keynote speaking to fundraising for the Leukemia & Lymphoma Society, Sandy's passion for people shines through every story.

In this week's episode we'll learn about Azacitidine in VEXAS syndrome. Treatment can provide responses in patients with this complex autoinflammatory disorder. But relapse rates were high, so long-term therapy may be required to maintain disease control. After that: A step forward in precision blood matching. High-throughput array genotyping enables extended matching to reduce antibody formation. The results show the potential for reducing harm in regularly transfused patients. Finally, identifying a new vulnerability in TP53-mutated AML. Loss of the tumor suppressor BAP1 defines a unique subtype of TP53-mutated de novo AML. BAP1 loss also confers sensitivity to BCL-xL inhibitors in vivo, opening a new therapeutic avenue.Featured ArticlesEfficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEXArray genotyping of transfusion-relevant blood cell antigens in 6946 ancestrally diverse study participantsLoss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors

In this Review Series episode, Associate Editor Dr. Hervé Dombret speaks with Dr. Mark Litzow about the latest immunotherapy advances for Acute Lymphoblastic Leukemia (ALL). The discussion highlights innovative treatments like blinatumomab and inotuzumab, which are showing remarkable success in clinical trials, including an 85% three-year survival rate and over 90% complete remission in elderly patients. Researchers are focusing on reducing chemotherapy intensity, developing personalized treatment approaches, and identifying optimal immunotherapy strategies for different ALL subtypes. The conversation underscores a promising shift towards more targeted, less toxic treatments that could significantly improve patient outcomes across various age groups and disease characteristics. These emerging therapies represent a potential paradigm shift in ALL treatment, offering hope for more effective and less aggressive therapeutic interventions.Read Dr. Litzow's paper “Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia” or find the whole review series on acute lymphoblastic leukemia in volume 145 issue 14 of Blood Journal. 

13th Annual Bachelor Auction for Blood Cancer benefiting Blood Cancer United (formerly Leukemia & Lymphoma Society)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.

In this episode, we sit down with Anastasia Cacavias, a registered nurse and manager of the Blood and Marrow Transplant Leukemia Program at Northside Hospital Cancer Institute in Atlanta. Anastasia walks us through the essential role that caregivers play throughout the transplant journey—from initial diagnosis to long-term recovery. Her perspective comes not only from clinical experience but from deeply personal connections with patients and their support systems.We begin by discussing the broad and intensive responsibilities caregivers take on. These range from medication management, symptom monitoring, transportation, and attending every medical appointment to providing emotional support 24/7. Anastasia explains how caregivers are not just passive companions but active partners in medical care. They're educated thoroughly before the patient begins their conditioning regimen, especially about signs of infection, graft-versus-host disease, and other complications.Once patients return home, the caregiver's role intensifies. They're responsible for maintaining a clean home environment, food preparation, hygiene assistance, and ensuring infection control—such as hand washing, mask-wearing, and visitor limitations. Anastasia offers guidance on how caregivers can prepare, including maintaining good communication, staying organized, and using a detailed education notebook provided by the hospital.Self-care for caregivers is a major focus. Anastasia emphasizes that it's okay to admit feeling overwhelmed. She encourages them to take breaks, get proper rest, eat well, and tap into family or community resources for support. Even small actions, like letting someone else bring the patient to the clinic for a few hours, can be meaningful.We also explore more medical territory—highlighting key patient needs such as hydration, nutrition, and mobility. Physical therapy is introduced before transplant and continued after, with an emphasis on realistic daily movement goals. Proper dental care, both pre- and post-transplant, is essential to avoid complications, with tips like using alcohol-free mouthwash and soft-bristled brushes.We touch on important transplant-related complications such as Graft-versus-Host Disease (GvHD) and Veno-Occlusive Disease (VOD). Anastasia details the signs to watch for, treatment protocols, and the hospital's proactive approach, including assigning dedicated GvHD nurses and maintaining 24/7 communication lines for urgent symptoms.Anastasia closes the conversation with moving stories of caregivers who went above and beyond—reminding us of the emotional strength and love that often fuels this journey. These stories reinforce her message: caregivers are central to healing. Without them, recovery would look very different.Northside Hospital: https://www.northside.com/National Marrow Donor Program (NMDP): https://bethematch.orgThis season is sponsored by Sanofi: https://www.sanofi.com/And Jazz Pharmaceuticals: https://www.jazzpharma.com/ National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, we speak with Daniel Medina of Broomfield, Colorado, about his journey as a caregiver for his wife Miley, who was diagnosed with acute myeloid leukemia (AML) in 2021 at the young age of 27. What begins as a story of sudden diagnosis during an active summer of volleyball quickly turned into an emotional and logistical rollercoaster for Daniel, Miley, and their then two-year-old daughter.We walk through the early days of Miley's diagnosis, including a pivotal urgent care visit that led directly to hospitalization. Daniel shares how a professional connection helped secure Miley's access to top oncological care at UC Health. Despite initial chemotherapy and some success, a relapse in 2022 led to a bone marrow transplant, which ultimately helped Miley recover and thrive. Today, she's healthier and more driven than ever—running three coffee shops, parenting energetically, and even making time for beach volleyball.Throughout the conversation, we dive deep into Daniel's experience as a male caregiver. He reflects on the challenges of holding together family life, work obligations, and emotional well-being while supporting a critically ill spouse. He shares how difficult it was to ask for help—something that went against his natural instinct for independence—and how family, colleagues, and mindfulness practices helped him cope.Daniel is candid about the helplessness he felt, the fears of losing his partner, and the emotional weight of trying to appear strong for his daughter. He explains how something as small as being physically present, even if it's just sitting silently in the hospital room, becomes powerful. We also learn how critical digital communities like the CancerBuddy app were in helping him find hope, practical advice, and emotional connection during a time when Google only offered grim statistics.We explore how Miley's recovery affected not only their family dynamics but also their daughter, who—despite her young age—continues to carry emotional echoes of the experience. Daniel highlights the importance of honoring milestones and using them to reflect on growth, healing, and gratitude. He encourages all caregivers to stay grounded, stay present, and reach out for support when needed. His perspective is not only honest and raw, but also deeply human, offering valuable insight into the caregiving journey from a role that's often underrepresented.This season is sponsored by Sanofi: https://www.sanofi.com/And Jazz Pharmaceuticals: https://www.jazzpharma.com/CancerBuddy: https://bonemarrow.org/support-and-financial-aid/support/about-cancerbuddy National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Greg Belfrage interviews Eric Van Beek about the Light The Night event that is coming up this weekend. The event is to raise money for the Leukemia and Lymphoma Society which helps with research to cure blood cancers. See omnystudio.com/listener for privacy information.

In this week's episode we'll learn about persistent changes in immune profiles in patients who have had diffuse large B-cell lymphoma, or DLBCL, and other cancers; that plasminogen activation and plasmin activity do not appear to play a role in routine physiological prevention of venous thromboembolism, or VTE; and about a novel mechanism that makes hematological malignancies carrying epigenetic mutations susceptible to PARP inhibitors.Featured Articles:Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatmentPlasminogen activation and plasmin activity are not required to prevent venous thrombosis/thromboembolismTransposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer

MD Anderson fellows discuss AML, MRD endpoints, and evolving trial strategies in a dynamic grand rounds–style presentation.

ReferencesPLoS One. 2014 Jul 1;9(7):e101607Front Mol Biosci. 2020 Feb 21;7:24.Leukemia 2010. volume 24, pages 679–686.Guerra, DJ. 2025. Unpublished LecturesMcQuinn, and Levy. 1970. Chestnut Mare Untitled LP BYRDShttps://music.youtube.com/watch?v=_SdiSjpOdyU&si=wKh4jFDuN8MT3bsrLewis and Carter. 1964. Little Bit of Soul. The Music Explosionhttps://music.youtube.com/watch?v=L9D6CWttXSs&si=AVufy0atavE5qchGGamble and Huff. 1967. Expressway to Your Heart. Soul Survivorshttps://music.youtube.com/watch?v=4EBYMl-f-wo&si=Qwi4svSr_PyYgWGvWithers, B. 1972. Lean on Me.https://music.youtube.com/watch?v=gOZgo8gMIoM&si=qu9K8eWBIR4VkqyOLennon/McCartney. 1963. With The Beatles lp.https://music.youtube.com/playlist?list=OLAK5uy_mM7D2y0gEKaLqXbK-nWgih4f-YHCmU-Ac&si=lnlchvIKOpukwVHqAnka, Revaux, Thibaut,Francois. 1969. My Way. Sinatrahttps://music.youtube.com/watch?v=qQzdAsjWGPg&si=fgrPIb2kpetLYiRb

In this week's episode, we'll learn about how TET2 is often mutated in myeloid malignancies and clonal hematopoiesis. In new work, expansion of Tet2-mutant HSPCs was dependent on Ncoa4, the cargo receptor mediating ferritinophagy. We'll iron out the implications. After that: a double-oh-seven license to kill in T-cell leukemia/lymphoma. WU-CART-007 is an off-the-shelf CAR T product with manageable safety and encouraging efficacy. With further work, it could become a new option for patients in urgent need of therapy. Finally: a comprehensive genetic study of classical Hodgkin lymphoma using circulating tumor DNA. This new research provides novel and complex insights on genetic subtypes, prognostic biomarkers, neoantigens in the disease environment, and more.Featured Articles:An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesisPhase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignanciesA comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA

PJ hears from Martina about how she chooses to keep pushing on and the good work done by CLL Ireland Hosted on Acast. See acast.com/privacy for more information.

In this episode of Take the Stage, Brad Bialy sits down with Shad Tidler to explore how staffing and recruiting firms can prevent sales objections before they arise and leverage AI to build a smarter, more human sales process. About the Guest Shad, a seasoned member of the Lushin sales team since 2014, combines his extensive global business expertise with the disciplined mindset of an Ironman triathlete. Specializing as a leading sales transformation consultant, he is known for crafting scalable strategies and processes tailored for client success. Shad's structured approach instills a sense of calm in clients, guiding them past immediate challenges and toward their goals. Beyond his professional pursuits, Shad enjoys swimming, biking, running, practicing martial arts, and traveling. He actively contributes to his community by volunteering at his local church, mentoring individuals within and outside his organization, and supporting the Leukemia and Lymphoma Society. However, above all else, Shad values his role as a devoted husband and friend. Key Takeaways Objections reveal problems earlier in the process. Desperation kills trust in sales. Sales is a series of small agreements. Abundance beats scarcity in prospecting. AI is a tool, not the solution. Timestamps [00:20] – Why objections mean you're already too late [02:50] – The trap of “we're different” pitches [05:11] – Shifting from qualifying in to disqualifying out [07:13] – Sales as small agreements, not one-call closes [09:43] – Letting prospects define next steps [11:44] – The roots of desperate selling [13:59] – Relationship analogies for rejection in sales [17:02] – Why being okay with “no” creates momentum [20:30] – Building structure around prospect follow-up [23:37] – Giving junior reps permission to experiment [27:17] – How AI is disrupting sales conversations [30:22] – Where staffing leaders should begin with AI About the Host Brad Bialy is a trusted voice and highly sought-after speaker in the staffing and recruiting industry, known for helping firms grow through integrated marketing, sales, and recruiting strategies. With over 13 years at Haley Marketing and a proven track record guiding hundreds of firms, Brad brings deep expertise and a fresh, actionable perspective to every engagement. He's the host of Take the Stage and InSights, two of the staffing industry's leading podcasts with more than 200,000 downloads. Sponsors and Offers Heard Take the Stage is presented by Haley Marketing. The old way of selling staffing is dead. Let's fix it – with smarter strategies and HUGE DISCOUNTS on modern lead gen tools: https://bit.ly/Bialy20 Book a 30-minute business and marketing consultation with host, Brad Bialy: https://bit.ly/Bialy30 For 30 years, Benefits in a Card has delivered benefit plans designed specifically for the staffing industry—over 140 unique options with immediate coverage, unique perks like FreeRx, and solutions that reduce turnover while improving ACA compliance. Give your workforce benefits they'll actually use and give your staffing firm a competitive edge. Learn more at https://www.BenefitsInACard.com.

Blood Editor, Dr. Thomas Coates interviews Dr. Emanuele Angelucci on his paper, "How I manage iron overload in the hematopoietic cell transplantation setting" which is featured in Blood's "How I Treat Series on Iron Overload in Hematologic Disorders". See the full How I Treat series in volume 145 issue 4 of Blood. 

In this week's episode we'll learn about targeting NPM1 in acute myeloid leukemia. Researchers report the first clinical evidence of a menin inhibitor inducing complete remissions in AML with a NPM1 mutation. This validates NPM1 as a new therapeutic target in AML, alongside FLT3, IDH1/2, and KMT2A. Also on the podcast: targeting CD137 to prevent graft-versus-host disease. In nonhuman primates, a single dose of a CD137 antibody-drug conjugate provided long-term protection, with one important caveat: the potential for viral reactivation.Featured Articles: Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 studyA single dose of a CD137 antibody–drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD

In this moving episode of Supply Chain Now, host Scott Luton sits down with Kristi Porter, Adrian Purtill, and Enrique Alvarez of Vector Global Logistics to explore a powerful story of purpose and community. Adrian shares a deeply personal initiative in honor of his late ex-wife, Kathy Purtill, who bravely battled leukemia. To carry her legacy forward, their son Kieran is climbing Mount Kilimanjaro to raise funds for the Leukemia & Lymphoma Society.This conversation goes beyond logistics, shining a light on the value of giving forward, building community, and leading with purpose. The Vector Global Logistics team reflects on how purpose-driven action can change lives—both in the global supply chain and beyond.Learn how you can support Kieran's mission, and be inspired to embrace the power of relationships, resilience, and purpose.Additional Links & Resources:Kathy Purtill's fundraising page for The Leukemia and Lymphoma Society: https://diy.lls.org/fundraiser/6467059Connect with Enrique: https://www.linkedin.com/in/enrique-alvarez-64332a2/Connect with Kristi: https://www.linkedin.com/in/kporter9876/Connect with Adrian: https://www.linkedin.com/in/adrian-purtill-947a2b5/Learn more about Vector Global Logistics: https://vectorgl.com/Learn more about Logistics with Purpose: https://logisticswithpurpose.co/Learn more about Supply Chain Now: https://supplychainnow.comWatch and listen to more Supply Chain Now episodes here: https://supplychainnow.com/program/supply-chain-nowSubscribe to Supply Chain Now on your favorite platform: https://supplychainnow.com/joinWork with us! Download Supply Chain Now's NEW Media Kit: https://bit.ly/3XH6OVkWEBINAR- Mastering Data in the AI Explosion Age - Managing the Fuel That Powers Innovation: https://bit.ly/4ogPN1kWEBINAR- Real stories: Fast-tracking value, a pioneering digital transformation with impactful results.: https://bit.ly/4mgp1EWWEBINAR: Real Shipping Stories. Real Money Saved.: https://bit.ly/45PegUmWEBINAR: From Compliance to Impact and Competitive Advantage: How to Decarbonize Your Supply Chain: https://bit.ly/47uXKKoThis episode is hosted by Scott Luton and produced by Trisha Cordes, Joshua Miranda, and Amanda Luton. For additional information, please visit our dedicated show page at: https://supplychainnow.com/honoring-legacy-moving-climbing-mountains-1473

Dr Azra Raza is a Professor of Medicine, Clinical Director of the Evans Foundation MDS Center, and Executive Director of The First Cell Coalition for Cancer Survivors at Columbia University in New York. She is the best-selling author of "The First Cell: And the human costs of pursuing cancer to the last". She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010. Before moving to New York, Dr Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards.TIMESTAMPS:(0:00) - Introduction (0:50) - The First Cell: and the human costs of pursuing cancer to the last(4:10) - Defining Cancer(7:50) - A Cancer Paradigm Shift: Finding the First Cell(11:16) - "The Cure for Cancer"(19:05) - Azra's Journey, Development & Reception(24:40) - Hope, Honesty & Harm in a Clinical Setting(33:00) - Current Medical Politics vs Revolutionary Detections/Treatments(39:00) - Increasing Lifespan & Healthspan(43:01) - "Michael Levin Should Win The Nobel Prize!"(51:00) - A Good Life & a Good Death(56:00) - How Words distort our relationship with Disease(1:00:00) - How Disease & Death Shape Our Lives(1:05:40) - The First Cell Book(1:09:15) - A Better Healthcare System(1:12:27) - Conclusion EPISODE LINKS:- Azra's Website: https://azraraza.com- Azra's Books: https://azraraza.com/books- Azra's X: https://x.com/AzraRazaMD- Azra's YouTube: http://www.youtube.com/@AzraRazaMDCONNECT:- Website: https://tevinnaidu.com - Podcast: https://creators.spotify.com/pod/show/mindbodysolution- YouTube: https://youtube.com/mindbodysolution- Twitter: https://twitter.com/drtevinnaidu- Facebook: https://facebook.com/drtevinnaidu - Instagram: https://instagram.com/drtevinnaidu- LinkedIn: https://linkedin.com/in/drtevinnaidu=============================Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

In this week's episode we'll learn about how by combining PET response with circulating tumor DNA, or  ctDNA, in newly treated patients with follicular lymphoma, investigators identify those patients likely to progress within 24 months of initial treatment, also known as POD24. After that: Immune hotspots in aplastic anemia. These newly identified hotspots potentially represent sites in the bone marrow where the active immune response takes place, driving the destruction of hematopoietic stem and progenitor cells. Finally, allogeneic transplantation for Hodgkin lymphoma in the checkpoint inhibitor era. In a large, retrospective study, patients with prior checkpoint inhibitor exposure had remarkable outcomes, particularly when post-transplant cyclophosphamide was used.Featured Articles: Combined PET and ctDNA response as predictors of POD24 for follicular lymphoma after first-line induction treatmentImaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic AnemiaOutcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis

In this week's episode, we'll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival prediction models to help guide management of patients with chronic myelomonocytic leukemia.Featured Articles:Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALLSequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopeniaBLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia

Dan Shaughnessy has watched The Jimmy Fund evolve throughout his time in Boston sports media. He also is confident that the Red Sox are a playoff team this season.

In this episode, Associate Blood editor Dr. Selina Luger leads a discussion with Drs. Courtney DiNardo, Eunice Wang, Andrew Wei and Gail Roboz about the advances in treatment options for Acute Myeloid Leukemia (AML). See the full How I Treat series on Acute Myeloid Leukemia in volume 145 issue 12 of Blood journal.

This week we explore the Pharaoh's tomb with Rachel and possibly discover the cause of the Curse of the Pharaoh. What's more, can it cure cancer? Rachel takes a look at Aspergillus fungus, how it causes disease but also has been used in experiments to cure Leukemia. Victoria is up next with a fascinating look at how spiders might be manipulating the flashing of fireflies in order to attract more prey. It's brand new research and wild. Kirk rounds out the show this week with a look at Mt Erebus in Antarctica. Not only is the most active volcano in the southern hemisphere, it has a permanent lava pool surrounded by snow and rains gold on Antarctica. This is a bizarre volcano. Join us weekly for more strange nature. Our supporters on Patreon get every episode ad-free!  Support us: patreon.com/strangebynature Email us: contact@strangebynaturepodcast.com Visit us at: strangebynaturepodcast.com  where you can sign up for our episode emails.

In this episode, we sit down with Abby Singh, a melanoma survivor diagnosed as an Adolescent and Young Adult (AYA). Abby is now the Director of Patient Content and Nutrition Education Services at The Leukemia & Lymphoma Society (LLS), where she creates critical resources for patients and caregivers, including the Survivorship Workbooks.She shares her journey through diagnosis, treatment, and survivorship, and how her experience drives her work supporting nutrition programs for all cancer types. Abby also opens up about life beyond cancer—from her Tennessee roots in Sevierville (Dolly Parton's hometown) to her passions for fiction writing, bar trivia, and family life.Join us for an honest, inspiring conversation about resilience, healing, and the importance of community in the AYA cancer experience.ABOUT OUR GUEST: Abby Singh, a melanoma survivor and passionate advocate for cancer patients, serves as the Director of Patient Content at the Nutrition Education Services Center and The Leukemia & Lymphoma Society (LLS). In this role, she has dedicated over a decade to creating impactful resources like the Survivorship Workbooks and supporting LLS's comprehensive nutrition program, which benefits individuals with all types of cancer.A proud graduate of Belmont University in Nashville, TN, Abby holds a bachelor's degree in English and history. She is also a member of the Alpha Gamma Delta sorority. Outside of her professional work, Abby enjoys reading, writing fiction, and testing her knowledge at bar trivia. She lives in Sevierville, TN—Dolly Parton's hometown—with her husband, young son, and two beloved cats.

What starts as a simple sore shoulder leads Megan Rafferty into a life-changing diagnosis of acute leukemia. Speaking to PJ Coogan Megan recounts her unexpected path through misdiagnosis, gruelling chemotherapy, sepsis, a bone marrow transplant, and the emotional rollercoaster of living with blood cancer. Hosted on Acast. See acast.com/privacy for more information.

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

Welcome back to part three of our hematology series here at Every Day Oral Surgery! Today, Drs. Andrew Jenzer and Maxwell Lloyd join Dr. Stucki to discuss all things leukemia. Tuning in, you'll hear all about the different kinds of leukemia, how we differentiate between them, symptoms of leukemia, and so much more! We delve into specific characteristics of acute myelogenous leukemia and how to avoid leukocytosis before discussing the role chemotherapy plays in treating different types of leukemia and the two different kinds of transplants these patients can have. We go on to discuss chronic myelogenous leukemia, the different phases associated with it, how chemotherapeutic medications may affect oral surgery procedures, how acute lymphocytic leukemia differs from other forms of leukemia, and how it's treated. Lastly, we dive into the most common kind of leukemia, chronic lymphocytic leukemia, the staging and prognosis of it, and so much more. This episode is jam-packed with important information that you don't want to miss out on, so be sure to press play now and tune in for the next episode!Key Points From This Episode:Welcoming today's guest, Dr. Maxwell Lloyd. A breakdown of some of the vocabulary doctors use in hematological care. What leukemia is and how we classify what kind of leukemia a patient has. Some general characteristics of all kinds of leukemia. Dr. Jenzer breaks down the characteristics of myeloid leukemia.What leukocytosis is, why it's so dangerous, and how we prevent it. How doctors treat AML (acute myelogenous leukemia). Using chemotherapy to treat leukemia and why it isn't enough on its own. The differences between autologous and allogeneic transplants. Breaking down CML (chronic myelogenous leukemia) and its phases.What ALL (acute lymphocytic leukemia) is and treatment options for it. We dive into the most common form of leukemia, CLL (chronic lymphocytic leukemia). Some important things to know about BTK inhibitors. Links Mentioned in Today's Episode:Dr. Andrew Jenzer — https://www.quintessence-publishing.com/usa/en/author/3920767/jenzer-andrew-clark Dr. Maxwell Lloyd Google Scholar — https://scholar.google.com/citations?user=D0agka0AAAAJ&hlSr. Louis OMFS Review — https://stlomfsreview.com/ Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

In this week's episode, we'll learn more about the effects of daratumumab maintenance on minimal residual disease in patients with newly diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in the pathophysiology of myeloproliferative neoplasms; and a genome-wide association study that identified novel genetic loci associated with the risk of heavy menstrual bleeding.Featured ArticlesDaratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease resultsDefective neutrophil clearance in JAK2^V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24Genome-wide meta-analysis of heavy menstrual bleeding reveals 36 risk loci

Shortly after Jonathan Pacheco was married, he unexpectedly found himself in the middle of the biggest trial of his life: leukemia. Given only months to live, he discovered rest and peace in the Lord and surrendered himself to God's will... when God worked yet another miracle. ++++++++++++ Compelled is a seasonal podcast using gripping, immersive storytelling to celebrate the powerful ways God is transforming Christians around the world. These Christian testimonies are raw, true, and powerful. Be encouraged and let your faith be strengthened! Want to help make new episodes? Either make a one-time gift, or become a Monthly Partner at: https://compelledpodcast.com/donate Perks of being a Monthly Partner include: EARLY ACCESS to each new Compelled episode 1 week early! FULL LIBRARY of our unedited, behind-the-scenes interviews with each guest... over 100+ hours of additional stories and takeaways! Become a Monthly Partner by selecting the "Monthly" option during check-out.  Show notes, emails, and more at: https://compelledpodcast.com Buy the Compelled book of testimonies, endorsed by Lee Strobel, Marvin Olasky, and more: https://compelledpodcast.com/book Compelled is a member of the Proclaim Podcast Network: https://proclaim.fm Learn more about your ad choices. Visit megaphone.fm/adchoices

Good Morning and E News: Hulk Hogan had leukemia, Taylor Swift in Happy Gilmore 2, Adam Sandler, Movies out this week, and Carrie Underwood.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this week's episode we'll learn more about enhanced transplant characteristics; targeting the JAK-STAT pathway with ruxolitinib in patients with adult-onset Still's disease and macrophage activation syndrome; and a pair of trials demonstrating lack of benefit for the anti-CD47 monoclonal antibody magrolimab in newly diagnosed acute myeloid leukemia.Featured ArticlesHeterogeneity of high-potency multilineage hematopoietic stem cells and identification of “Super” transplantabilityRuxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndromeMagrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 studyThe ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy

Interview with Melanie Comito, MD

Gedit, Gedit Friday! What would you do if you were a billionaire?... Flash house?, Help the issues of the world?, Retire your family?... Well the boys know what they'd do... Matua Marc came to the show a little while ago with his segment "Shell We" a chance for Shifters to share something they were proud about, their story, their rise through trials and tribulations, a safe place... Well a Shifter who wrote in back then, now has an update for us all... One that made the boys reflect... Deano Collins is not only a friend of the show but come the 5th of September, he is doing some unbelievable mahi... He is spending 24hrs going up against a boxing bag to raise funds and awareness for the Child Cancer Foundation as his Son Houston was diagnosed with Leukemia in 2023... Hit that link below to stay caught up with anything and everything TMS. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.facebook.com/groups/3394787437503676/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We dropped some merch! Use TMS for 10% off. Here is the link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youknowclothing.com/search?options%5Bprefix%5D=last&q=tms⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Thank you to the team at Chemist Warehouse for helping us keep the lights on, here at The Morning Shift... ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.chemistwarehouse.co.nz⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of F-Stop Collaborate and Listen, host Matt Payne chats with photographer Geoffrey Giebelhaus about the Fediverse—a decentralized network of social media platforms like Mastodon and PixelFed that offer an alternative to the algorithm-driven, ad-heavy giants like Instagram and Facebook. Geoffrey breaks down what the Fediverse is, how it works, and why it's a great fit for photographers seeking a more ethical, community-focused space to share their work. The conversation covers the learning curve of moving to decentralized platforms, the importance of hashtags and alt text, tips for getting started, and how the Fediverse empowers users to keep their followers and content, no matter where they go. They also touch on the deeper creativity and connections fostered by this new social media landscape, and close with Geoffrey's advocacy for the Leukemia and Lymphoma Society of Canada. If you're fed up with mainstream social media and want to learn about a more authentic and user-driven alternative, this episode is for you. Links: Geoff's awesome blog about the Fediverse Support the podcast on Patreon Join my newsletter The Leukemia & Lymphoma Society  

Send us a textJonathan Daige is an Army veteran with two deployments to Iraq. A retired Worcester Police officer of 18 years and served 8 years on the SWAT Team as a sniper. Within that time he has battled testicular cancer that spread all over his body from his chest to his brain multiple times. After cycling to heal he began a nonprofit Thin Blue Ride that helps military veterans, first responders and their families when battling cancer. Since 2017 Thin Blue Ride has raised over $800,000 for families across the country. JD now medically retired has been battling Leukemia for several years and is continuing to help cancer warriors whenever he can. Find Jonathan DaigeWebsiteFind The Suffering PodcastThe Suffering Podcast InstagramKevin Donaldson InstagramTom Flynn InstagramApple PodcastSpotifyYouTubeThe Suffering Podcast FamilySherri AllsupSupport the showThe Suffering Podcast Instagram Kevin Donaldson Instagram TikTok YouTube

ICYMI, this hot take episode originally aired in April of this year. One of America's most notorious TV moms sat down with me and gave me a great interview. Barbara Bregoli, the mother of Danielle Bregoli, famously known as Bhad Bhabie or the "Cash Me Outside" girl. Barbara shared her life story, from her Brooklyn upbringing and career in finance to the challenges of being a single mother. She opened up about the infamous Dr. Phil appearance, clarifying misconceptions and discussing Bhad Bhabie's evolution into a rapper. Barbara also revealed her personal battles with breast cancer and the impact on her family, as well as the recent news of Dani's leukemia diagnosis. Through it all, Barbara's resilience and unwavering support for her daughter shone brightly, offering a deeply personal and inspiring narrativeTimestamps:00:00:00 - Introduction and Guest Welcome00:00:20 - Barbara Bregoli's Background and Dr. Phil Appearance00:00:50 - The Origin of "Catch Me Outside" Phrase00:28:03 - Bhad Bhabie's Leukemia Diagnosis00:30:36 - Alabama Barker Feud, Bhad Bhabie's OF earnings and more00:35:17 - The Kardashian's, Bhad Bhabie's future goals and moreMY Go Big Podcasting Courses Are Here! Purchase Go Big Podcasting and learn to start, monetize, and grow your own podcast. Use code DAD15 for 15% OFF until 6/30/2025**SHOP my Amazon Marketplace - especially if you're looking to get geared-up to start your own Podcast!!!**https://www.amazon.com/shop/thesarahfrasershowShow is sponsored by:ASPCA Pet Insurance to explore coverage, visit A-S-P-C-A pet insurance dot com slash TSFS.Horizonfibroids.com get rid of those nasty fibroidsNutrafol.com use code TSFS for FREE shipping and $10 off your subscriptionQuince.com/tsfs for FREE shipping on your order and 365 day returnsRula.com/tsfs to get started today. That's R-U-L-A dot com slash tsfs for convenient therapy that's covered by insurance.Thrivecosmetics.com/tsfs Brighten a mom's day—especially if you're that mom. Go to thrivecausemetics.com/TSFS for 20% OFF your orderFollow me on Instagram/Tiktok: @thesarahfrasershow ***Visit our Sub-Reddit: reddit.com/r/thesarahfrasershow for ALL things The Sarah Fraser Show!!!***Advertise on The Sarah Fraser Show: thesarahfrasershow@gmail.comGot a juicy gossip TIP from your favorite TLC or Bravo show? Email: thesarahfrasershow@gmail.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.